- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Pamlab, L.L.C
Total 759 results
-
Centocor Ortho Biotech Services, L.L.C.CompletedArthritis, Rheumatoid
-
Centocor Ortho Biotech Services, L.L.C.Completed
-
Pamlab, Inc.Baylor Health Care System; Red Oak Psychiatry Associates, PACompletedMajor Depressive DisorderUnited States
-
Palmaz ScientificClinLogix. LLCCompleted
-
University of FloridaSomna Therapeutics, L.L.C.RecruitingGERD | Lung TransplantUnited States
-
Johnson & Johnson Pharmaceutical Research & Development...Approved for marketingUrogenital Neoplasms | Genital Neoplasms, Male | Prostate Neoplasms | Genital Diseases, MaleUnited States, Australia, Hong Kong, Spain, Colombia, Mexico, Poland, Malaysia, Romania, Canada, Greece, Taiwan, Korea, Republic of, New Zealand, Singapore, Brazil, Russian Federation, Czech Republic, Puerto Rico, Thailand, Hungary and more
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedConstipationChina, Taiwan, Australia, Korea, Republic of, Thailand
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedAsthmaGermany, United Kingdom
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedMajor Depressive DisorderUnited States
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedSchizophreniaUnited States, Ukraine, Germany, Spain, India, Russian Federation, Czech Republic, Austria, Hungary, Lithuania, Bulgaria, Estonia, Poland, France
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedSchizophreniaUnited States, Ukraine, Taiwan, Malaysia, Romania, Russian Federation, Serbia, Korea, Republic of
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedGastroesophageal RefluxUnited States
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedAsthmaUnited States, India, Canada, Romania
-
Johnson & Johnson Pharmaceutical Research & Development...TerminatedTinea PedisPoland, United Kingdom
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedDiabetes Mellitus, Type 2Korea, Republic of, United States, Germany
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedMusculoskeletal DiseasesUnited States, Costa Rica, Argentina, Brazil, Chile, Israel, Mexico, Panama
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedBreast CancerUnited States, Poland, Ukraine, United Kingdom, Spain, Israel, Bulgaria, Romania, Serbia, South Africa, Russian Federation, Hungary, Lithuania, Netherlands, Latvia, Portugal, Estonia, France
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedPsychotic Disorders | Schizophrenia | Bipolar DisorderUnited States
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedSchizophreniaTaiwan, Malaysia, Romania, South Africa, Ukraine, Korea, Republic of, Russian Federation, Bulgaria, Lithuania, Estonia
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedSchizophreniaBelgium, Germany, Russian Federation, Slovakia, Sweden
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedBipolar DisorderUnited States, Ukraine, Taiwan, Spain, Poland, India, Malaysia, Russian Federation, Slovakia, Austria
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedHeart FailureBelgium, Germany, Poland, Romania
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedRheumatoid ArthritisUnited States, Germany
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedAttention Deficit Hyperactivity DisorderUnited States
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedSexual Dysfunction | Erectile DysfunctionFrance, Poland, United States, Belgium, Mexico, Malaysia, Canada, Taiwan, Korea, Republic of, Russian Federation, Argentina, Australia, United Kingdom
-
Johnson & Johnson Pharmaceutical Research & Development...TerminatedVentilator-Associated PneumoniaUnited States, Australia, Germany, France, Spain, Argentina, Mexico, Portugal, India, Romania, Turkey, Ukraine, Canada, Belgium, Brazil, Philippines, Russian Federation, Hungary, Israel, Thailand, Guatemala
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedMild Cognitive ImpairmentUnited States, United Kingdom, Belgium, Germany, Spain, Argentina, Israel, Poland, Australia, Canada, Netherlands, Finland, Austria, Sweden, France, Czech Republic